Metastases
74
5
7
41
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
14 trials with published results (19%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.5%
10 terminated out of 74 trials
80.4%
-6.1% vs benchmark
23%
17 trials in Phase 3/4
34%
14 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 41 completed trials
Clinical Trials (74)
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors
Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer
Exercise Training in Women With Metastatic Breast Cancer
68Ga-PSMA PET in the Renal Cell Carcinoma
Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients
High Dose Radiotherapy for Palliation (Hi-D)
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa
EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers
SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors
Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status
Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors
Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease
68Ga-PSMA PET in the Prostate Cancer
Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer